Recognized for its prowess in the M&A space, Goodwin advises clients from the pharmaceutical, AI, fintech, and real estate industries on tender offers, divestitures and take-privates, and spin offs, in addition to acting on both the private and public side for mature clients. With experience in the regulatory, transactional, and antitrust elements of M&A, the group is collectively led by Boston-based Michael Kendall, who concentrates on corporate finance, private equity, and venture capital deals. Silicon Valley- based co-head Lawrence Chu is well-verse in handling global M&A for tech companies, while co-head Joshua Zachariah covers corporate governance and strategic M&A representations from the firm’s New York office. Also in Boston is Stuart Cable, who has ample experience in representing boards of directors in life sciences-focused M&A.
Legal 500 Editorial commentary

Key clients

  • Ansys
  • Cvent Holding Corp
  • Deciphera Pharmaceuticals
  • EQRx
  • Fusion Pharmaceuticals
  • Novo Holdings
  • Qatalyst Partners
  • Qualtrics International Inc.
  • Retina Consultants of America
  • Thoma Bravo

Lawyers

Practice head

Michael Kendall; Lawrence Chu; Joshua Zachariah

Other key lawyers

Stuart Cable